Key Findings Disparities in outcomes across different patient groups defined based on race, ethnicity, gender, age, socio-economic factors, and other factors are significant and can be attributed to many intersectional drivers related to healthcare awareness, access and delivery, in addition to factors related to genetics While access and delivery of care are major factors driving disparities in outcomes, a comprehensive clinical development program that addresses diversity and ranges from pre-clinical and exploratory studies through randomized confirmatory trials for safety and efficacy through to post-approval real-world studies can advance understanding of optimal patient care, expand access to care, bring earlier insights, and accelerate innovation Stakeholders in the U.S
Results showed that carnitine significantly improved sperm motility and shape, though it didnt have a measurable effect on sperm count or increase pregnancy rates
While not all inclusive, a few of the potential future indications that are being explored for GLP1 receptor agonists are listed below
Nrf2, nuclear factor erythroid 2-related factor 2
[Updated Jul 25, 2021]